Early phase study to assess efficacy and safety of AZD9567 versus prednisolone in patients with rheumatoid arthritis

Trial Identifier: D6470C00003
Sponsor: AstraZeneca
NCTID:: NCT03368235
Start Date: January 2018
Primary Completion Date: November 2019
Condition: Rheumatoid Arthritis

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Swedish Translation
Dutch Translation

Trial Locations

Country Location
Denmark Frederiksberg, Denmark, 2000
Netherlands Enschede, Netherlands, 7512 KZ
Netherlands Maastricht, Netherlands, 6229 HX
Netherlands UTRECHT, Netherlands, 3584 CX
Sweden Göteborg, Sweden, 413 45
Sweden Lund, Sweden, 221 85
Sweden Uppsala, Sweden, 751 85